Suppression of allogeneic T cells proliferation by CD3/CD46-induced T-regulatory 1 cells

Abstract

CD46 is not only identified as a complement regulatory protein which protects host cells from complement attack, but also a new co-stimulatory molecule for human T cells. CD3/CD46 co-stimulation can induce a T-regulatory 1 cell (Tr1)-specific cytokine phenotype in human CD4⁺ T cells. However, the role of CD46 as a co-stimulatory molecule in the modulation of the acquired immunity, such as transplant immunology, remains unclear. In this study, CD4⁺ T cells were isolated from human CD46-transgenic C57BL/6 mice by magnetic-activated cell sorting, and further induced by anti-CD3, anti-CD28 and anti-CD46 antibodies respectively, and anti-CD3/anti-CD28 antibodies, anti-CD3/anti-CD46 antibodies, or the monoclonal antibody panel against CD3/CD28/CD46. The levels of interleukin-2 (IL-2), γ-interferon (γ-IFN), interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) were detected in the supernatants of different groups. Suppression of allogeneic T cell proliferation were assessed by using mixed lymphocyte reaction (MLR) assay, in which monoclonal antibodies against CD46 were added to the culture. The results showed that CD3/CD28, CD3/CD46 and CD3/CD28/CD46 co-stimulation could significantly induce stronger proliferation of T cells than CD3 stimulation (P<0.05), and CD3/CD28/CD46 co-stimulation significantly increased the proliferation of T cells when compared with CD3/CD28 or CD3/CD46 co-stimulation (P<0.05 for each). IL-2 and γ-IFN levels were much higher in CD3/CD28 co-stimulation group than in CD3, CD28, CD46 and CD3/CD46 groups (P<0.05 for each). IL-10 and TGF-β levels were dramatically increased in CD3/CD46 co-stimulation group as compared with those in the CD3, CD28, CD46 and CD3/CD28 groups (P<0.05 for each). CD3/CD46 co-stimulation significantly inhibited the T cell proliferation and allogenic immune responses through the secretion of IL-10 and TGF-β in MLR (P<0.05). These results suggested that CD3/CD46 can induce Tr1 cells to modulate allogenic immune responses, and it may become a novel target for the development of new therapeutic approach for T-cell-mediated diseases. CD46 plays an important role in regulating the T cell-mediated immune responses by bridging innate and acquired immunity.

Keywords

CD46 / co-stimulatory molecule / T-regulatory 1 cells / allogenic immune response

References

[1] BattagliaM., GregoriS., BacchettaR., et al.. Tr1 cells: from discovery to their clinical application. Semin Immuno, 2006, 18(2): 120-127

[2] CottrezF., GrouxH.. Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation, 2004, 77(1Suppl): S12-15

[3] Barilla-LaBarcaM.L., LiszewskiM.K., LambrisJ.D., et al.. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J Immuno, 2002, 168(12): 6298-6304

[4] ManchesterM., NanicheD., StehleT.. CD46 as a measles receptor: form follows function. Virology, 2000, 274(1): 5-10

[5] GillD.B., AtkinsonJ.P.. CD46 in Neisseria pathogenesis. Trends Mol Med, 2004, 10(9): 459-465

[6] AssemM.M., GadW.H., El-SharkawyN.M., et al.. Prevalence of anti human herpes virus-6 IgG and its receptor in acute leukemia (membrane cofactor protein: MCP, CD46). J Egypt Natl Canc Inst, 2005, 17(1): 29-34

[7] GiannakisE., JokirantaT.S., OrmsbyR.J., et al.. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol, 2002, 168(9): 4585-4592

[8] AstierA., Trescol-BiemontM.C., AzocarO., et al.. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol, 2000, 164(12): 6091-6095

[9] KemperC., ChanA.C., GreenJ.M., et al.. Activation of human CD4⁺ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature, 2003, 421(6921): 388-392

[10] AstierA.L.. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology, 2008, 124(2): 149-154

[11] Riley-VargasR.C., GillD.B., KemperC., et al.. CD46: expanding beyond complement regulation. Trends Immunol, 2004, 25(9): 496-503

[12] KemperC., LeungM., StephensenC.B., et al.. Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol, 2001, 124(2): 180-189

[13] JohanssonL., RytkonenA., WanH., et al.. Human-like immune responses in CD46 transgenic mice. J Immunol, 2005, 175(1): 433-440

[14] MarieJ.C., AstierA.L., RivaillerP., et al.. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol, 2002, 3(7): 659-666

[15] SanchezA., FeitoM.J., RojoJ.M.. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4⁺ T lymphocytes. Eur J Immunol, 2004, 34(9): 2439-2448

[16] GrouxH.. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation, 2003, 75(9Suppl): 8S-12S

[17] LevingsM.K., RoncaroloM.G.. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol, 2000, 106(1Pt2): S109-112

[18] WaldmannH., GracaL., CobboldS., et al.. Regulatory T cells and organ transplantation. Semin Immunol, 2004, 16(2): 119-126

[19] RoncaroloM.G., GregoriS., BattagliaM., et al.. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev, 2006, 212: 28-50

[20] BattagliaM., StabiliniA., DraghiciE., et al.. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes, 2006, 55(1): 40-49

[21] BacchettaR., GregoriS., RoncaroloM.G.. CD4⁺ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev Nov, 2005, 4(8): 491-496